Pfizer COVID Vaccine 90 Percent Effective in Trials, Company May Request Approval by End of November
FEATURES
- Wilford Woodruff: Determined to Go on His Mission at all Hazards by Kristy Wheelwright Taylor
- Podcast: What Women Don’t Get Told About Their Pelvic Floor by Michaela Proctor Hutchins
- A Testimony Can Bend Yet Still Stand by Paul Bishop
- The Deep Questions of Noah’s Flood: Come Follow Me–Genesis 6-11, Moses 8 by Scot and Maurine Proctor
- Opinion: Is anyone else exhausted by all the shows pretending to represent Latter-day Saint women? by Deseret News
- The Weeping Voice of Enoch by Jeffrey M. Bradshaw
- Packing our Cold-Weather Gear for the Joseph Smith Documentaries Project by Scot and Maurine Proctor
- Your Hardest Family Question: My daughter and her child moved in with us during her divorce by Geoff Steurer, MS, LMFT
- How the Church Is Celebrating the 250th Anniversary of the United States by Larry Richman
- Three Creation Accounts – One Divine Plan by Paul Bishop
















Comments | Return to Story
Pauline HarryNovember 13, 2020
No long-term safety has been proven in this 2-month trial. The study reports only .02% of the study group from ALL OVER THE WORLD which doesn’t take into account how many cases are there are there, nutrition, weather, or lifestyle. And now they’re ready to start vaccinating millions! Throw tons of money at it and see if anyone sticks around?
Pauline HarryNovember 12, 2020
Pfizer's CEO cashed out 60% of his stock on the same day the company unveiled the results of its COVID-19 vaccine trial. Could end up helping to spread the virus.
ADD A COMMENT